RR
Rushikumarkanaiyalal Ribadiya
About Rushikumarkanaiyalal Ribadiya
Data last updated:
Rushikumarkanaiyalal Ribadiya is a Director at Symbiosis Bioscience Private Limited (since 2023), Director at Axter Pharmaceuticals Private Limited (since 2020) and Designated Partner at Symbiosis Biolife Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.55 Cr; the largest is Symbiosis Bioscience Private Limited at ₹4.13 Cr (FY 2025). Earlier, Rushikumarkanaiyalal Ribadiya was a Director at Laxter Pharmaceuticals Private Limited (2019–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Oct 2023 | 2022 | ₹4.13 Cr (FY 2025) | Active | |
| Director | 06 Mar 2020 | 2014 | ₹3.43 Cr (FY 2025) | Active | |
| Designated Partner | 11 Mar 2024 | 2024 | Active | ||
| Director | 20 Oct 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 May 2019 | 2018 | ₹1.51 Cr (FY 2023) | Under Process Of Striking Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rushikumarkanaiyalal Ribadiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jagdish Pravinbhai Hirani | 06919912 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited and 1 more | Director |
| Kuldeep Kanaiyalal Ribadiya | 06919929 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited | Director |
| Sagar Pravinbhai Hirani | 06919987 | Symbiosis Bioscience Private Limited , Axter Pharmaceuticals Private Limited and 1 more | Director |
| Sakshi Laller | 10163397 | Symbiosis Bioscience Private Limited , Symbiosis Biolife Llp | Director |
| Jagbir Singh | 00821561 | Lifekyor Overseas Private Limited | Director |
| Manubhai Nagjibhai Jiyani | 07846986 | Lifekyor Overseas Private Limited | Director |
| Namankumar Kanubhai Trapsia | 06920249 | Lifekyor Overseas Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rushikumarkanaiyalal Ribadiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rushikumarkanaiyalal Ribadiya
Rushikumarkanaiyalal Ribadiya currently holds 4 directorships: Symbiosis Bioscience Private Limited (Director, since 17 Oct 2023, revenue ₹4.13 Cr (FY 2025)); Axter Pharmaceuticals Private Limited (Director, since 06 Mar 2020, revenue ₹3.43 Cr (FY 2025)); Symbiosis Biolife Llp (Designated Partner, since 11 Mar 2024); Lifekyor Overseas Private Limited (Director, since 20 Oct 2017).
Rushikumarkanaiyalal Ribadiya was first appointed on 20 Oct 2017 as Director at Lifekyor Overseas Private Limited. The most recent appointment on record is 11 Mar 2024 at Symbiosis Biolife Llp.
The 2 current companies of Rushikumarkanaiyalal Ribadiya that report revenue have a combined latest revenue of ₹7.55 Cr: Symbiosis Bioscience Private Limited ₹4.13 Cr (FY 2025); Axter Pharmaceuticals Private Limited ₹3.43 Cr (FY 2025).
Rushikumarkanaiyalal Ribadiya held 1 earlier board appointment: Laxter Pharmaceuticals Private Limited (Director, 09 May 2019 to 22 Jan 2021).
The current boards of Rushikumarkanaiyalal Ribadiya's companies include Jagdish Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Kuldeep Kanaiyalal Ribadiya (Symbiosis Bioscience Private Limited), Sagar Pravinbhai Hirani (Symbiosis Bioscience Private Limited), Sakshi Laller (Symbiosis Bioscience Private Limited), Jagbir Singh (Lifekyor Overseas Private Limited), Manubhai Nagjibhai Jiyani (Lifekyor Overseas Private Limited), among others.